Shover CL - Search Results

1

Association between medical cannabis laws and opioid overdose mortality has reversed over time.

Shover CL, Davis CS, Gordon SC, Humphreys K. Shover CL, et al. Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12624-12626. doi: 10.1073/pnas.1903434116. Epub 2019 Jun 10. Proc Natl Acad Sci U S A. 2019. PMID: 31182592 Free PMC article.

2

Six policy lessons relevant to cannabis legalization.

Shover CL, Humphreys K. Shover CL, et al. Am J Drug Alcohol Abuse. 2019;45(6):698-706. doi: 10.1080/00952990.2019.1569669. Epub 2019 Mar 14. Am J Drug Alcohol Abuse. 2019. PMID: 30870053 Free PMC article. Review.

3

The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs.

Shover CL, Abraham A, D'Aunno T, Friedmann PD, Humphreys K. Shover CL, et al. J Subst Abuse Treat. 2019 Oct;105:44-50. doi: 10.1016/j.jsat.2019.07.012. Epub 2019 Jul 29. J Subst Abuse Treat. 2019. PMID: 31443890 Free PMC article.

4

Predictors of availability of long-acting medication for opioid use disorder.

Shover CL, Humphreys K. Shover CL, et al. Drug Alcohol Depend. 2019 Nov 1;204:107586. doi: 10.1016/j.drugalcdep.2019.107586. Epub 2019 Sep 25. Drug Alcohol Depend. 2019. PMID: 31593871 Free PMC article.

5

Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industry.

Humphreys K, Shover CL. Humphreys K, et al. Among authors: shover cl. World Psychiatry. 2020 Jun;19(2):191-192. doi: 10.1002/wps.20739. World Psychiatry. 2020. PMID: 32394570 Free PMC article. No abstract available.

6

Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.

Shover CL, Vest NA, Chen D, Stueber A, Falasinnu TO, Hah JM, Kim J, Mackey I, Weber KA 2nd, Ziadni M, Humphreys K. Shover CL, et al. JAMA Netw Open. 2020 Jul 1;3(7):e2010001. doi: 10.1001/jamanetworkopen.2020.10001. JAMA Netw Open. 2020. PMID: 32662844 Free PMC article.

7

Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?

Shover CL, Humphreys K. Shover CL, et al. Cureus. 2020 Jun 17;12(6):e8671. doi: 10.7759/cureus.8671. Cureus. 2020. PMID: 32699671 Free PMC article.

8

Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance.

Shover CL, Falasinnu TO, Dwyer CL, Santos NB, Cunningham NJ, Freedman RB, Vest NA, Humphreys K. Shover CL, et al. Drug Alcohol Depend. 2020 Nov 1;216:108314. doi: 10.1016/j.drugalcdep.2020.108314. Epub 2020 Sep 28. Drug Alcohol Depend. 2020. PMID: 33038637 Free PMC article.

9

Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study.

Shover CL, Falasinnu TO, Freedman RB, Humphreys K. Shover CL, et al. J Addict Med. 2021 Sep-Oct 01;15(5):429-431. doi: 10.1097/ADM.0000000000000775. J Addict Med. 2021. PMID: 33234804 Free PMC article.

10

Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuéllar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Humphreys K, et al. Among authors: shover cl. Lancet. 2022 Feb 5;399(10324):555-604. doi: 10.1016/S0140-6736(21)02252-2. Epub 2022 Feb 2. Lancet. 2022. PMID: 35122753 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page